Stockholders' Equity (Deficit) (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Sep. 05, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Stockholders' Equity | |||
| Common stock shares, authorized | 300,000,000 | ||
| Common stock shares, par value | $ 0.0001 | $ 0.0001 | |
| Offering costs paid | $ 2,909,740 | ||
| Placement Agent Warrants | |||
| Stockholders' Equity | |||
| Warrants to purchase (in shares) | 586,666 | ||
| Exercise price | $ 3 | ||
| Warrant, grant date fair value per share | $ 1.617 | ||
| Warrant, grant-date fair value | $ 948,639 | ||
| Placement Agent Warrants | Earlier of (i) Five years after the Closing Date | |||
| Stockholders' Equity | |||
| Warrant expiration term (in years) | 5 years | ||
| Placement Agent Warrants | Earlier of (ii) Three years after the listing of common stock on NSE | |||
| Stockholders' Equity | |||
| Warrant expiration term (in years) | 3 years | ||
| Private Placement | |||
| Stockholders' Equity | |||
| Issuance of common stock (in shares) | 10,000,000 | ||
| Purchase price (in dollars per share) | $ 3 | ||
| Offering costs paid | $ 2,909,740 |
| X | ||||||||||
- Definition Grant date fair value per share or per unit of warrants or rights. No definition available.
|
| X | ||||||||||
- Definition The total grant date fair value of warrants or rights issued. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|